Clene Announces Additional CNM-Au8 Biomarker Data Supporting Potential NDA Filing for Upcoming In-Person FDA Meeting

Stock Information for Clene Inc.

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About Clene Inc.

Presenting on Emerging Growth Conference 89 Day 1 on January 21; Register to live stream
Clene to Present at the Emerging Growth Conference
Clene Announces Registered Direct Offering of Over $28 Million
Clene to Present at the Emerging Growth Conference
Presenting on Emerging Growth Conference 88 Day 1 on December 10; Register to live stream
Clene Announces Statistically Significant ALS Biomarker Results Supporting Accelerated Approval Pathway for CNM-Au8®
Clene to Provide CNM-Au8® ALS Program Update
Clene to Participate at the Benchmark 14th Annual Discovery One-on-One Investor Conference

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.